Influence of reserpine and dihydrazinophthalazine on cerebrospinal fluid and blood catecholamines in the hypertensive disease.
D000328:Adult; D000959:Antihypertensive Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001812:Blood-Brain Barrier; D002395:Catecholamines / Q000097:blood* / Q000134:cerebrospinal fluid*; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004837:Epinephrine / Q000097:blood / Q000134:cerebrospinal fluid; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood / Q000134:cerebrospinal fluid; D011724:Pyridazines / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology* / Q000627:therapeutic use
D000959:Antihypertensive Agents; D002395:Catecholamines; D011724:Pyridazines; D012110:Reserpine; D009638:Norepinephrine; D004837:Epinephrine